We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
121 hedge funds and large institutions have $1.68B invested in Atara Biotherapeutics in 2018 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 39 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
205% more call options, than puts
Call options by funds: $4.58M | Put options by funds: $1.5M
54% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 13
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
5% more funds holding
Funds holding: 115 → 121 (+6)
5% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 39
0.14% more ownership
Funds ownership: 4.09% → 4.23% (+0.14%)
13% less capital invested
Capital invested by funds: $1.92B → $1.68B (-$240M)
Holders
121
Holders Change
+6
Holders Change %
+5.22%
% of All Funds
2.7%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
20
Increased
41
Reduced
39
Closed
13
Calls
$4.58M
Puts
$1.5M
Net Calls
+$3.08M
Net Calls Change
+$4.51M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$20.5M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$12.5M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.2M |
| 4 |
HCM
Highline Capital Management
New York
|
+$10.8M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$10.4M |
Top Sellers
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$17.2M |
| 2 |
State Street
Boston,
Massachusetts
|
-$15.6M |
| 3 |
BM
Bridger Management
New York
|
-$9.37M |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
-$4.13M |
| 5 |
Goldman Sachs
New York
|
-$3.22M |
